Condition
Hemobilia
Total Trials
1
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
2 treatments under study, led by Ercp Endoscopic Retrograde Cholangiopancreatography
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 1 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
Trial Status
Completed1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (1)
Research Network
Common Treatments
- Ercp Endoscopic Retrograde Cholangiopancreatography1
- Spyglass Dvs And Spyglass Digital Simple Ds1
Active Sponsors
- Boston Scientific Corporation1
Top Investigators
Royal Adelaide Hospital
Prince of Wales Hospital, Shatin, Hong Kong
Kinki University School of Medicine
King Chulalongkorn Memorial Hospital
Teikyo University Mizonokuchi Hospital
Related Conditions
- Biliary Obstruction Due To Common Bile Duct Stone1
- Biliary Stricture1
- Periampullary Tumor1